It is premature to ascribe risk of cardiac arrhythmias or other adverse effects to celecoxib, but with more than one million prescriptions of Celebrex every month, the data make a case for exploring the implications of its inhibition of hERG and other human channels critical to cardiac rhythm and other physiological functions. This evidence concerns the gene KCNH2 and chronic obstructive pulmonary disease.